-
1
-
-
0009529293
-
Downregulation of cytokine synthesis during cardiopulmonary bypass
-
1a. Börgermann J, Friedrich I, Feldt T, et al. Down-regulation of cytokine synthesis during cardiopulmonary bypass. Shock 1997; 8 (Suppl): 114.
-
(1997)
Shock
, vol.8
, Issue.SUPPL.
, pp. 114
-
-
Börgermann, J.1
Friedrich, I.2
Feldt, T.3
-
2
-
-
0025805047
-
Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune golbulin to neonates with clinical signs of early-onset sepsis
-
1b. Christensen RD, Brown MS, Hall DC, Lassiter HA, Hill HR. Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune golbulin to neonates with clinical signs of early-onset sepsis. J Pediatr 1991; 118: 606-614.
-
(1991)
J Pediatr
, vol.118
, pp. 606-614
-
-
Christensen, R.D.1
Brown, M.S.2
Hall, D.C.3
Lassiter, H.A.4
Hill, H.R.5
-
3
-
-
0021247249
-
Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa
-
2. Collins MS, Roby RE. Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa. Am J Med 1984; 76: 168-174.
-
(1984)
Am J Med
, vol.76
, pp. 168-174
-
-
Collins, M.S.1
Roby, R.E.2
-
4
-
-
0016044643
-
Therapeutic intervention scoring system: A method for quantitative comparison of patient care
-
3. Cullen DJ, Civetta JM, Briggs BA, et al. Therapeutic intervention scoring system: a method for quantitative comparison of patient care. Crit Care Med 1974; 2: 57-60.
-
(1974)
Crit Care Med
, vol.2
, pp. 57-60
-
-
Cullen, D.J.1
Civetta, J.M.2
Briggs, B.A.3
-
5
-
-
0032586351
-
Outcome assessment - The pros and cons of TISS as the primary objective
-
4. Dellinger RP. Outcome assessment - the pros and cons of TISS as the primary objective. Eur J Surg 1999; Suppl 584: 49-50.
-
(1999)
Eur J Surg
, Issue.SUPPL. 584
, pp. 49-50
-
-
Dellinger, R.P.1
-
6
-
-
0023241561
-
Untersuchung sur Wirksamkeit von Immunglobulin M-angereicherten, intravenösen Immunglobulinen gegen bakterielle Infektionen und sur Neutralisation bakterieller Toxine
-
5. Dichtelmüller H, Stephan W. Untersuchung sur Wirksamkeit von Immunglobulin M-angereicherten, intravenösen Immunglobulinen gegen bakterielle Infektionen und sur Neutralisation bakterieller Toxine. Arsneim Forsch Drug Res 1987; 11: 1273-1276.
-
(1987)
Arsneim Forsch Drug Res
, vol.11
, pp. 1273-1276
-
-
Dichtelmüller, H.1
Stephan, W.2
-
7
-
-
0024277322
-
IgM-Antikörper gegen das Toxic-shock Syndrom Toxin-1 in Humanseren und Human-Immmunglobulinen
-
6. Dickgiesser N, Düsgün F. IgM-Antikörper gegen das Toxic-shock Syndrom Toxin-1 in Humanseren und Human-Immmunglobulinen. Klin Wochenschr 1988; 66: 7-11.
-
(1988)
Klin Wochenschr
, vol.66
, pp. 7-11
-
-
Dickgiesser, N.1
Düsgün, F.2
-
8
-
-
0032586355
-
Considerations on the statistical design of the ATMI-study
-
7. Eisebitt R, Lehmacher W, Lefering R. Considerations on the statistical design of the ATMI-study. Eur J Surg 1999; Suppl 584: 68-69.
-
(1999)
Eur J Surg
, Issue.SUPPL. 584
, pp. 68-69
-
-
Eisebitt, R.1
Lehmacher, W.2
Lefering, R.3
-
9
-
-
0029918478
-
Postoperative mediastinitis: Classification and management
-
8. El Oakley RM, Wright JE. Postoperative mediastinitis: classification and management. Ann Thorac Surg 1996; 61: 1030-1036.
-
(1996)
Ann Thorac Surg
, vol.61
, pp. 1030-1036
-
-
El Oakley, R.M.1
Wright, J.E.2
-
10
-
-
0024550748
-
Opsonic activity of a new intravenous immunoglobulin preparation: Pentaglobin® compared with Sandoglobulin
-
9. Garbett ND, Munro CS, Cole PJ. Opsonic activity of a new intravenous immunoglobulin preparation: Pentaglobin® compared with Sandoglobulin. Clin Exp Immunol 1989; 76: 8-12.
-
(1989)
Clin Exp Immunol
, vol.76
, pp. 8-12
-
-
Garbett, N.D.1
Munro, C.S.2
Cole, P.J.3
-
11
-
-
0019426197
-
Complement activation and neutropenia occurring during cardiopulmonary bypass
-
10. Hammerschmidt D, Storncek D, Bowers T, et al. Complement activation and neutropenia occurring during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1981; 81: 370-377.
-
(1981)
J Thorac Cardiovasc Surg
, vol.81
, pp. 370-377
-
-
Hammerschmidt, D.1
Storncek, D.2
Bowers, T.3
-
12
-
-
0022745346
-
Protective and opsonic activities of a native pH 4.25 intravenous immunoglobulin G preparation against common bacterial pathogens
-
11. Hill HR, Bathras JM. Protective and opsonic activities of a native pH 4.25 intravenous immunoglobulin G preparation against common bacterial pathogens. Rev Infect Dis 1986; 8(Suppl): S396-S400.
-
(1986)
Rev Infect Dis
, vol.8
, Issue.SUPPL.
-
-
Hill, H.R.1
Bathras, J.M.2
-
13
-
-
0026475958
-
Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass
-
12. Jansen NJ, van Oevren W, Gu YJ, van Vliet MH, Eijsman L, Wildevuur CR. Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. Ann Thorac Surg 1992; 54: 744-747.
-
(1992)
Ann Thorac Surg
, vol.54
, pp. 744-747
-
-
Jansen, N.J.1
Van Oevren, W.2
Gu, Y.J.3
Van Vliet, M.H.4
Eijsman, L.5
Wildevuur, C.R.6
-
14
-
-
0020959670
-
Therapeutic intervention scoring system: Update 1983
-
13. Keene AR, Cullen DJ. Therapeutic Intervention Scoring System: update 1983. Crit Care Med 1983; 11: 1-3.
-
(1983)
Crit Care Med
, vol.11
, pp. 1-3
-
-
Keene, A.R.1
Cullen, D.J.2
-
15
-
-
0009524355
-
Pathomechanisms of defective hemostasis during and after extracorporeal circulation: Contact activation
-
Friedel N, Hetser R, Royston D, eds. Darmstadt: Steinkopff
-
14. Kluft C. Pathomechanisms of defective hemostasis during and after extracorporeal circulation: contact activation. In: Friedel N, Hetser R, Royston D, eds: Bolld use in cardiac surgery. Darmstadt: Steinkopff, 1991: 10-15.
-
(1991)
Bolld Use in Cardiac Surgery
, pp. 10-15
-
-
Kluft, C.1
-
16
-
-
0032586350
-
Thoracic transposition of the greater omentum as an adjunct in the treatment of mediastinitis - Pros and cons within the context of a randomised trial
-
15. Krabatsch T, Schmitt DV, Mohr FW, Hetzer R. Thoracic transposition of the greater omentum as an adjunct in the treatment of mediastinitis - pros and cons within the context of a randomised trial. Eur J Surg 1999; Suppl 584: 45-48.
-
(1999)
Eur J Surg
, Issue.SUPPL. 584
, pp. 45-48
-
-
Krabatsch, T.1
Schmitt, D.V.2
Mohr, F.W.3
Hetzer, R.4
-
17
-
-
0009498329
-
Reduced incidence of postoperative infection following intravenous application of an IgM and IgM-enriched immunoglobulin preparation in anergic patients undergoing cardiac surgery
-
in press
-
16. Kress HG, Seidewig C, Schmidt H, Silber R. Reduced incidence of postoperative infection following intravenous application of an IgM and IgM-enriched immunoglobulin preparation in anergic patients undergoing cardiac surgery. Crit Care Med: in press,
-
Crit Care Med
-
-
Kress, H.G.1
Seidewig, C.2
Schmidt, H.3
Silber, R.4
-
18
-
-
0000550066
-
Objektivierung der Organ (dys-)funktion in der Intensivmedisin - Warum und wie?
-
17. Lefering R, Neugebauer E. Objektivierung der Organ (dys-)funktion in der Intensivmedisin - Warum und wie? Intensivmed 1998; 35: 177-181.
-
(1998)
Intensivmed
, vol.35
, pp. 177-181
-
-
Lefering, R.1
Neugebauer, E.2
-
19
-
-
0031324251
-
Effektivkosten der Intensivtherapie: TISS und TISS-28 zur Evaluation einer Intensivstation
-
18. Lefering R, Zart M, Neugebauer E. Effektivkosten der Intensivtherapie: TISS und TISS-28 zur Evaluation einer Intensivstation. Langenbecks Arch Chir (Suppl II) 1997; 1393.
-
(1997)
Langenbecks Arch Chir
, Issue.SUPPL. II
, pp. 1393
-
-
Lefering, R.1
Zart, M.2
Neugebauer, E.3
-
20
-
-
0032586354
-
Biostatistical aspects of outcome evaluation using TISS-28
-
19. Lefering R. Biostatistical aspects of outcome evaluation using TISS-28. Eur J Surg 1999; Suppl 584: 56-61.
-
(1999)
Eur J Surg
, Issue.SUPPL. 584
-
-
Lefering, R.1
-
21
-
-
0032586346
-
Efficacy and potential clinical applications of Pentaglobin®, an IgM-enriched immunoglobulin concentrate suitable for intravenous infusion
-
20. Lissner R, Struff WG, Autenrieth IB, Woodcock BG, Karch H. Efficacy and potential clinical applications of Pentaglobin®, an IgM-enriched immunoglobulin concentrate suitable for intravenous infusion. Eur J Surg; Suppl 584: 17-25.
-
Eur J Surg
, Issue.SUPPL. 584
, pp. 17-25
-
-
Lissner, R.1
Struff, W.G.2
Autenrieth, I.B.3
Woodcock, B.G.4
Karch, H.5
-
22
-
-
0025219806
-
Sternal wound complications after isolated coronary artery bypass grafting: Early and late mortality, morbidity, and cost of care
-
21. Loop FD, Lytle BW, Cosgrove DM, et al. Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity, and cost of care. Ann Thorac Surg 1990; 49: 179-187.
-
(1990)
Ann Thorac Surg
, vol.49
, pp. 179-187
-
-
Loop, F.D.1
Lytle, B.W.2
Cosgrove, D.M.3
-
24
-
-
0024553333
-
Opsonic activitiy in serum from septic infants treated with intravenous immunoglobulin
-
23. Marödi L, Kalmár A, Ssabó I. Opsonic activitiy in serum from septic infants treated with intravenous immunoglobulin. Arch Dis Child 1989; 64: 530-534.
-
(1989)
Arch Dis Child
, vol.64
, pp. 530-534
-
-
Marödi, L.1
Kalmár, A.2
Ssabó, I.3
-
25
-
-
0032586353
-
Organ dysfunction as an outcome measure in clinical trials
-
24. Marshall JC. Organ dysfunction as an outcome measure in clinical trials Eur J Surg 1999; Suppl 584: 62-67.
-
(1999)
Eur J Surg
, Issue.SUPPL. 584
, pp. 62-67
-
-
Marshall, J.C.1
-
26
-
-
0028208797
-
Multicenter trials in sepsis and septic shock. Necessary prerequisites elaborated on the trial of supplemental immunoglobulin treatment of Pilz et al
-
25. Neugebauer E. Multicenter trials in sepsis and septic shock. Necessary prerequisites elaborated on the trial of supplemental immunoglobulin treatment of Pilz et al. Theor Surg 1994; 9: 60-62.
-
(1994)
Theor Surg
, vol.9
, pp. 60-62
-
-
Neugebauer, E.1
-
27
-
-
0032586344
-
Development of a consensus-assisted protocol - A new approach to improve study design
-
26. Neugebauer E. Development of a consensus-assisted protocol - a new approach to improve study design. Eur J Surg 1999; Suppl 584: 7-11.
-
(1999)
Eur J Surg
, Issue.SUPPL. 584
, pp. 7-11
-
-
Neugebauer, E.1
-
28
-
-
0001172828
-
Modulation of the humoral mediator network in the treatment of shock and sepsis
-
Okada K, Ogata H, eds. Amsterdam: Elsevier
-
27. Neugebauer E, Schäfer U, Rixen D, Bouillon B. Modulation of the humoral mediator network in the treatment of shock and sepsis. In: Okada K, Ogata H, eds: Shock from molecular and cellular level to whole body. Amsterdam: Elsevier; 1996: 275-288.
-
(1996)
Shock from Molecular and Cellular Level to Whole Body
, pp. 275-288
-
-
Neugebauer, E.1
Schäfer, U.2
Rixen, D.3
Bouillon, B.4
-
29
-
-
84938030174
-
Septic shock: Hemodynamics and pathogensesis
-
28. Parker MM, Parrillo JE. Septic shock: hemodynamics and pathogensesis. JAMA 1983; 250: 3324-3327.
-
(1983)
Jama
, vol.250
, pp. 3324-3327
-
-
Parker, M.M.1
Parrillo, J.E.2
-
30
-
-
0027532444
-
Supplemental immunoglobulin treatment in sepsis and septic shock - Comparison of mortality under treatment with polyvalent i.v. immunoglobulin versus placebo. Protocol of a multicenter, randomised, prospective, double-blind trial
-
29. Pilz G, Fateh-Moghadam S, Viell B, et al. Supplemental immunoglobulin treatment in sepsis and septic shock -comparison of mortality under treatment with polyvalent i.v. immunoglobulin versus placebo. Protocol of a multicenter, randomised, prospective, double-blind trial. Theor Surg 1993; 8: 61-83.
-
(1993)
Theor Surg
, vol.8
, pp. 61-83
-
-
Pilz, G.1
Fateh-Moghadam, S.2
Viell, B.3
-
31
-
-
0032586352
-
Outcome assessment - TISS as a tool to evaluate cost-effectiveness of immunological treatment
-
30. Reis Miranda D. Outcome assessment - TISS as a tool to evaluate cost-effectiveness of immunological treatment. Eur J Surg 1999; Suppl 584: 51-55.
-
(1999)
Eur J Surg
, Issue.SUPPL. 584
, pp. 51-55
-
-
Reis Miranda, D.1
-
32
-
-
0029898011
-
Simplified therapeutic intervention scoring system: The TISS-28 items - Results from a multicenter study
-
31. Reis Miranda D, De Rijk A, Schaufli WB. Simplified therapeutic intervention scoring system: the TISS-28 items - results from a multicenter study. Crit Care Med 1996; 24: 64-73.
-
(1996)
Crit Care Med
, vol.24
, pp. 64-73
-
-
Reis Miranda, D.1
De Rijk, A.2
Schaufli, W.B.3
-
33
-
-
0009463491
-
Blocking of complement activation by intravenously applicable IgG, -M, and -A preparations: Analysis of the efficacy of C4b-and C3b-scavenging
-
Innsbruck, March 12-15
-
32. Rieben R, Gerritsen AF, Nydegger UE, Daha MR. Blocking of complement activation by intravenously applicable IgG, -M, and -A preparations: analysis of the efficacy of C4b-and C3b-scavenging. 6th European Meeting on Complement in Human Disease, Innsbruck, March 12-15; 1997.
-
(1997)
6th European Meeting on Complement in Human Disease
-
-
Rieben, R.1
Gerritsen, A.F.2
Nydegger, U.E.3
Daha, M.R.4
-
34
-
-
0032586348
-
Comments on the study protocol: Adjuvant treatment of mediastinitis (ATMI) with immunoglobulins (Pentaglobin®) after cardiac surgery
-
33. Robicsek F. Comments on the study protocol: Adjuvant treatment of mediastinitis (ATMI) with immunoglobulins (Pentaglobin®) after cardiac surgery. Eur J Surg 1999; Suppl 584: 39-42.
-
(1999)
Eur J Surg
, Issue.SUPPL. 584
, pp. 39-42
-
-
Robicsek, F.1
-
35
-
-
0027745701
-
Effects of interleukin-2 treatment in patients with common variable immunodeficiency (CVID)
-
34. Rump JA, Jahreis A, Schlesier M, et al. Effects of interleukin-2 treatment in patients with common variable immunodeficiency (CVID). Immunodeficiency 1993; 4: 37-42.
-
(1993)
Immunodeficiency
, vol.4
, pp. 37-42
-
-
Rump, J.A.1
Jahreis, A.2
Schlesier, M.3
-
36
-
-
0028897194
-
Complement activation and release of tumor necrosis factor-alpha, interleukin-2, and soluble tumor necrosis factor and interleukin-2 receptors during and after cardiopulmonary bypass in children
-
35. Saatvedt K, Lindberg H, Geiran OR, et al. Complement activation and release of tumor necrosis factor-alpha, interleukin-2, and soluble tumor necrosis factor and interleukin-2 receptors during and after cardiopulmonary bypass in children. Scan J Clin Lab Invest 1995; 55: 79-86.
-
(1995)
Scan J Clin Lab Invest
, vol.55
, pp. 79-86
-
-
Saatvedt, K.1
Lindberg, H.2
Geiran, O.R.3
-
37
-
-
0021131296
-
Mediastinal infection after cardiac surgery
-
36. Sarr MG, Gott VL, Townsend R. Mediastinal infection after cardiac surgery. Ann Thorac Surg 1984; 38: 415-424.
-
(1984)
Ann Thorac Surg
, vol.38
, pp. 415-424
-
-
Sarr, M.G.1
Gott, V.L.2
Townsend, R.3
-
38
-
-
0029922017
-
A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor concentrations and outcome of patients with severe sepsis
-
37. Schade FU. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor concentrations and outcome of patients with severe sepsis. Crit Care Med 1996; 24: 381-384.
-
(1996)
Crit Care Med
, vol.24
, pp. 381-384
-
-
Schade, F.U.1
-
39
-
-
0032586358
-
Relation of the bi-allelic NcoI restriction fragment length polymorphism within the tumour necrosis factor b gene to the development of mediastinitis
-
38. Schade FU, Stüber F, Börgermann J, Majetschak M. Relation of the bi-allelic NcoI restriction fragment length polymorphism within the tumour necrosis factor b gene to the development of mediastinitis. Eur J Surg 1999; Suppl 584: 73-78.
-
(1999)
Eur J Surg
, Issue.SUPPL. 584
, pp. 73-78
-
-
Schade, F.U.1
Stüber, F.2
Börgermann, J.3
Majetschak, M.4
-
40
-
-
0032586349
-
Microbiology and antibiotic treatment - Discussion forum on a study protocol on adjuvant treatment of mediastinitis with immunoglobulin (Pentaglobin®) after cardiac surgery (ATMI)
-
39. Solomkin JS. Microbiology and antibiotic treatment -Discussion forum on a study protocol on adjuvant treatment of mediastinitis with immunoglobulin (Pentaglobin®) after cardiac surgery (ATMI). Eur J Surg 1999; Suppl 584: 43-44.
-
(1999)
Eur J Surg
, Issue.SUPPL. 584
, pp. 43-44
-
-
Solomkin, J.S.1
-
41
-
-
0031028218
-
Cytokine responses to cardiopulmonary bypass: Lessons learned from cardiac transplantation
-
40. Song W, LeClere JL, Vincent JL. Cytokine responses to cardiopulmonary bypass: Lessons learned from cardiac transplantation. Ann Thorac Surg 1997; 63: 269-276.
-
(1997)
Ann Thorac Surg
, vol.63
, pp. 269-276
-
-
Song, W.1
LeClere, J.L.2
Vincent, J.L.3
-
43
-
-
0002722030
-
Intravenous immunoglobulins inhibit LPS-induced TNFα- release from human monocytic cells
-
Faist E, ed. Mondussi Editore March 4-8
-
42. Trautmann M, Karajan MA, Susa M, Marre R, Gansauge F. Intravenous immunoglobulins inhibit LPS-induced TNFα-release from human monocytic cells. In: Faist E, ed. 4th International Congress on the Immune Consequences of Trauma, Shock and Sepsis. Mondussi Editore March 4-8; 1997: 775-779.
-
(1997)
4th International Congress on the Immune Consequences of Trauma, Shock and Sepsis
, pp. 775-779
-
-
Trautmann, M.1
Karajan, M.A.2
Susa, M.3
Marre, R.4
Gansauge, F.5
-
44
-
-
0033291932
-
Immunological monitoring of the inflammatory process: Which variables? When to assess?
-
43. Volk HD, Reinke P, Döcke WD. Immunological monitoring of the inflammatory process: Which variables? When to assess? Eur J Surg 1999; Suppl 584: 70-72.
-
(1999)
Eur J Surg
, Issue.SUPPL. 584
, pp. 70-72
-
-
Volk, H.D.1
Reinke, P.2
Döcke, W.D.3
-
45
-
-
0032586347
-
The overall concept: Immunoglobulins as adjuvants for mediastinitis - Does it make sense?
-
44. Werdan K. The overall concept: immunoglobulins as adjuvants for mediastinitis - Does it make sense? Eur J Surg 1999; Suppl 584: 33-38.
-
(1999)
Eur J Surg
, Issue.SUPPL. 584
, pp. 33-38
-
-
Werdan, K.1
-
46
-
-
0029996366
-
Supplemental immunoglobulins in sepsis: A critical appraisal
-
45. Werdan K, Pilz G. Supplemental immunoglobulins in sepsis: a critical appraisal. Clin Exp Immunol 1996; 104: 83-90.
-
(1996)
Clin Exp Immunol
, vol.104
, pp. 83-90
-
-
Werdan, K.1
Pilz, G.2
-
47
-
-
0029739445
-
Immunomodulatory effect of immunoglobulins
-
46. Wolf HM, Eibl MM. Immunomodulatory effect of immunoglobulins. Clin Exp Rheumatol 1996; 14(Suppl 15): 517-525.
-
(1996)
Clin Exp Rheumatol
, vol.14
, Issue.SUPPL. 15
, pp. 517-525
-
-
Wolf, H.M.1
Eibl, M.M.2
|